Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...

Peijia Medical, a China-based domestic medical device company focused on transcatheter valve therapeutics and neurovascular inter ...

March 19, 2026—iVascular announced 1-year results from the BARISTA clinical trial, which is evaluating the safety and efficacy of the company&rs ...

March 18, 2026—iVascular announced 3-year follow-up results from the LUMIFOLLOW registry, a large real-world study evaluating ...

Terumo Aortic announced that the FDA has granted Breakthrough Device designation for the company’s fenestrated Treo abdomin ...

Imperative Care, Inc., a developer of treatments for thromboembolic disease, announced the closing of a $100 million ...

Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of ...

Boston Scientific announced FDA clearance for the “Any Day Dosing” feature on the company’s TheraSphere 360 ytt ...

Cook Medical announced it has selected Indiana University (IU) in Indianapolis, Indiana, as one of the first Interventional ...

Three-year outcomes from the PERFORMANCE II trial studying the Neuroguard Integrated Embolic Protection (IEP) 3-in-1 Carotid Sten ...

IceCure Medical Ltd. announced that the FDA has approved the study design for the ChoICE trial, the company’s postmarketing ...

Toro Neurovascular announced FDA 510(k) clearance and commercial introduction of the Toro 88 superbore catheter, a ...